Obseva SA (NASDAQ:OBSV) is trading higher slightly in the pre-market session.
OBSV Released News late Tuesday
ObsEva Announces Proposed Changes to the Composition of its Board of Directors
- announced that its Board of Directors will propose the election at the 2021 Annual General Meeting of Shareholders to be held on May 28, 2021 of Anne VanLent as member of the Board of Directors for a term of one year expiring at the closing of the 2022 Annual General Meeting of Shareholders.
- Anne VanLent is a seasoned senior life sciences executive with over 35 years of management and governance experience with emerging growth companies. Since 2008, Anne has provided strategic, financial and management consulting services to emerging growth companies in the life sciences and technology arenas through her consulting company AMV Advisors.
- Assignments have included strategic financial funding and structuring advice, mergers and acquisitions transaction support, and interim Chief Financial Officer services. She has been a member of the board of directors of at least one public company consistently for over twenty years, serving 10 different medical device and biopharmaceutical public companies.
- She currently serves as a member of the board of directors and audit committee chair for Applied Genetics Technologies Corporation (NASDAQ: AGTC) and Trevi Therapeutics, Inc. (NASDAQ: TRVI).
On Tuesday, OBSV stock is up 1.79% to $2.84 in the pre-market session. The stock ended lower 3.13% to $2.79 on Tuesday with more than 579K shares traded hands for the session, compared to its 30-day average volume of 1.21 million shares.